Overview

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its...

Open

$17.09

Prior close

$17.02

Today's high

$17.30

Today's low

$17.09

52 Week high

$18.39

52 Week low

$9.43

News

PRNewsWire • 3 days ago • VTRS

Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome

Seeking Alpha • 9 days ago • VTRS

Viatris: Strong Cash Generation And Pipeline Progress Keep The Re-Rating Story Alive

Zacks Investment Research • 9 days ago • VTRS

Viatris (VTRS) is a Top-Ranked Value Stock: Should You Buy?

Proactive Investors • 22 days ago • VTRS

Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris

Zacks Investment Research • 22 days ago • VTRS

3 Generic Drug Stocks to Watch Amid Improving Industry Trends